ADMA Biologics Inc (ADMA)
21.86
-0.47
(-2.10%)
USD |
NASDAQ |
Apr 25, 16:00
21.89
+0.03
(+0.14%)
After-Hours: 20:00
ADMA Biologics Max Drawdown (5Y): 84.37% for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
Emergent BioSolutions Inc | 98.89% |
Biomarin Pharmaceutical Inc | 53.26% |
Catalyst Pharmaceuticals Inc | 60.03% |
TG Therapeutics Inc | 93.19% |
Ocular Therapeutix Inc | 90.94% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 36.07 |
Beta (5Y) | 0.5272 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 55.70% |
Historical Sharpe Ratio (5Y) | 0.799 |
Historical Sortino (5Y) | 1.744 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.17% |